{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T18:30:39Z","timestamp":1782930639979,"version":"3.54.5"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ijbiomac.2025.143080","type":"journal-article","created":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T17:25:24Z","timestamp":1744478724000},"page":"143080","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P4","title":["Targeting friend leukemia integration 1: A promising approach for prevention and treatment of solid tumors"],"prefix":"10.1016","volume":"309","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1416-720X","authenticated-orcid":false,"given":"Moumita","family":"Kundu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankita","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallab Kumar","family":"Maji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3861-3323","authenticated-orcid":false,"given":"Mahitosh","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2025.143080_bb0005","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.neo.2014.08.007","article-title":"FLI1 expression is correlated with breast cancer cellular growth, migration, and invasion and altered gene expression","volume":"16","author":"Scheiber","year":"2014","journal-title":"Neoplasia"},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0010","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.3390\/ijms24031881","article-title":"Fli1 and tissue fibrosis in various diseases","volume":"24","author":"Mikhailova","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0015","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1038\/s41467-024-48397-9","article-title":"FLI1 promotes IFN-\u03b3-induced kynurenine production to impair antitumor immunity","volume":"15","author":"Chen","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0020","doi-asserted-by":"crossref","first-page":"15173","DOI":"10.3390\/ijms242015173","article-title":"EWS\/FLI1 characterization, activation, repression, target genes and therapeutic opportunities in Ewing sarcoma","volume":"24","author":"Yasir","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0025","doi-asserted-by":"crossref","DOI":"10.21608\/bmfj.2021.93529.1472","article-title":"The significance of friend leukemia virus integration 1 transcription factor (Fli-1) in astrocytoma","author":"Ahmed","year":"2022","journal-title":"Benha Med. J."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0030","doi-asserted-by":"crossref","first-page":"29174","DOI":"10.18632\/oncotarget.16303","article-title":"Overexpression of Fli-1 in astrocytoma is associated with poor prognosis","volume":"8","author":"Tsai","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0035","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1038\/onc.2014.162","article-title":"The ets transcription factor Fli-1 in development, cancer and disease","volume":"34","author":"Li","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0040","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13059-018-1594-y","article-title":"A novel FLI1 exonic circular RNA promotes metastasis in breast cancer by coordinately regulating TET1 and DNMT1","volume":"19","author":"Chen","year":"2018","journal-title":"Genome Biol."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijscr.2024.109642","article-title":"Ewing sarcoma with intra thoracic and multiple extra thoracic metastases in a young adult male: a case report","volume":"118","author":"Soeroso","year":"2024","journal-title":"Int. J. Surg. Case Rep."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0050","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3390\/cancers15010272","article-title":"Current state of immunotherapy and mechanisms of immune evasion in Ewing sarcoma and osteosarcoma","volume":"15","author":"Evdokimova","year":"2022","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0055","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1128\/MCB.00241-13","article-title":"A novel role for keratin 17 in coordinating oncogenic transformation and cellular adhesion in Ewing sarcoma","volume":"33","author":"Sankar","year":"2013","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0060","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ccell.2014.10.004","article-title":"EWS-FLI1 utilizes divergent chromatin remodeling mechanisms to directly activate or repress enhancer elements in Ewing sarcoma","volume":"26","author":"Riggi","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0065","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/s41419-022-05275-w","article-title":"TrkC, a novel prognostic marker, induces and maintains cell survival and metastatic dissemination of Ewing sarcoma by inhibiting EWSR1-FLI1 degradation","volume":"13","author":"Kim","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25168595","article-title":"EWS-FLI1 and activator protein-1 (AP-1) reciprocally regulate extracellular-matrix proteins in Ewing sarcoma cells","volume":"25","author":"Croushore","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0075","doi-asserted-by":"crossref","DOI":"10.1172\/JCI169470","article-title":"Oncogenic ETS fusions promote DNA damage and proinflammatory responses via pericentromeric RNAs in extracellular vesicles","volume":"134","author":"Ruzanov","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0080","doi-asserted-by":"crossref","first-page":"9047","DOI":"10.1158\/0008-5472.CAN-09-1540","article-title":"EWS\/FLI and its downstream target NR0B1 interact directly to modulate transcription and oncogenesis in Ewing\u2019s sarcoma","volume":"69","author":"Kinsey","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0085","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1038\/sj.onc.1210991","article-title":"The EWS\/FLI1 oncogenic transcription factor deregulates GLI1","volume":"27","author":"Zwerner","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0090","doi-asserted-by":"crossref","first-page":"9074","DOI":"10.1074\/jbc.M806233200","article-title":"GLI1 is a direct transcriptional target of EWS-FLI1 oncoprotein","volume":"284","author":"Beauchamp","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007608","article-title":"GLI1 is a central mediator of EWS\/FLI1 signaling in Ewing tumors","volume":"4","author":"Joo","year":"2009","journal-title":"PloS One"},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0100","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.4161\/cc.8.13.8929","article-title":"Epigenetic maintenance of stemness and malignancy in peripheral neuroectodermal tumors by EZH2","volume":"8","author":"Burdach","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0105","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.1073\/pnas.0810759106","article-title":"EZH2 is a mediator of EWS\/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation","volume":"106","author":"Richter","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0110","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1158\/0008-5472.CAN-07-1761","article-title":"EWS-FLI-1 expression triggers a Ewing\u2019s sarcoma initiation program in primary human mesenchymal stem cells","volume":"68","author":"Riggi","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0115","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41419-020-2265-y","article-title":"Polymerase independent repression of FoxO1 transcription by sequence-specific PARP1 binding to FoxO1 promoter","volume":"11","author":"Tian","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109254","article-title":"NELL2-cdc42 signaling regulates BAF complexes and Ewing sarcoma cell growth","volume":"36","author":"Jayabal","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0125","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.4161\/cc.29337","article-title":"Ewing sarcoma EWS protein regulates midzone formation by recruiting Aurora B kinase to the midzone","volume":"13","author":"Park","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0130","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41392-020-00265-w","article-title":"The potent roles of salt-inducible kinases (SIKs) in metabolic homeostasis and tumorigenesis","volume":"5","author":"Sun","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0135","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.4251\/wjgo.v13.i10.1367","article-title":"Diverse roles of FOXO family members in gastric cancer","volume":"13","author":"Chen","year":"2021","journal-title":"World J. Gastrointest. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0140","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.freeradbiomed.2022.09.018","article-title":"Thiostrepton confers protection against reactive oxygen species-related apoptosis by restraining FOXM1-triggerred development of gastric cancer","volume":"193","author":"Liu","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2023.03.007","article-title":"FOXM1: a small fox that makes more tracks for cancer progression and metastasis","volume":"92","author":"Khan","year":"2023","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.626836","article-title":"FOXM1 and cancer: faulty cellular signaling derails homeostasis","volume":"10","author":"Kalathil","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0155","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ccr.2006.04.004","article-title":"Expression profiling of EWS\/FLI identifies NKX2.2 as a critical target gene in Ewing\u2019s sarcoma","volume":"9","author":"Smith","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0160","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1158\/1541-7786.MCR-11-0524","article-title":"STEAP1 is associated with the invasive and oxidative stress phenotype of Ewing tumors","volume":"10","author":"Grunewald","year":"2012","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0165","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/onc.2013.541","article-title":"The histone demethylase KDM3A is a microRNA-22-regulated tumor promoter in Ewing sarcoma","volume":"34","author":"Parrish","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0170","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1038\/onc.2017.44","article-title":"The histone demethylase KDM3A, and its downstream target MCAM, promote Ewing sarcoma cell migration and metastasis","volume":"36","author":"Sechler","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0175","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.smim.2013.10.023","article-title":"The interleukin-1 receptor family","volume":"25","author":"Boraschi","year":"2013","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0180","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1158\/1535-7163.MCT-13-0447","article-title":"Blocking SDF-1\u03b1\/CXCR4 downregulates PDGF-B and inhibits bone marrow\u2013derived pericyte differentiation and tumor vascular expansion in Ewing tumors","volume":"13","author":"Hamdan","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.onc.1206055","article-title":"Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS\/ets protein in Ewing sarcoma","volume":"22","author":"Fukuma","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0190","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1158\/1078-0432.CCR-03-0038","article-title":"Vascular endothelial growth factor expression is upregulated by EWS-ETS oncoproteins and Sp1 and May represent an independent predictor of survival in Ewing\u2019s sarcoma","volume":"10","author":"Fuchs","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0195","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/13854","article-title":"Repression of the gene encoding the TGF-\u03b2 type II receptor is a major target of the EWS-FLI1 oncoprotein","volume":"23","author":"Hahm","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0200","doi-asserted-by":"crossref","first-page":"7275","DOI":"10.1128\/MCB.24.16.7275-7283.2004","article-title":"EWS\/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3","volume":"24","author":"Prieur","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0205","doi-asserted-by":"crossref","first-page":"5089","DOI":"10.1038\/onc.2012.525","article-title":"Mechanism and relevance of EWS\/FLI-mediated transcriptional repression in Ewing sarcoma","volume":"32","author":"Sankar","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0210","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bbrc.2010.09.129","article-title":"FOXO1 is a direct target of EWS-Fli1 oncogenic fusion protein in Ewing's sarcoma cells","volume":"402","author":"Yang","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0215","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00138-19","article-title":"EWSR1-FLI1 activation of the cancer\/testis antigen FATE1 promotes Ewing sarcoma survival","volume":"39","author":"Gallegos","year":"2019","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0220","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s12943-024-02115-7","article-title":"Pharmacological targeting of P300\/CBP reveals EWS::FLI1-mediated senescence evasion in Ewing sarcoma","volume":"23","author":"Wei","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0225","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMra2028910","article-title":"Ewing\u2019s sarcoma","volume":"384","author":"Riggi","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0230","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.ccell.2021.07.003","article-title":"TRIM8 modulates the EWS\/FLI oncoprotein to promote survival in Ewing sarcoma","volume":"39","author":"Seong","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0235","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1158\/0008-5472.CAN-09-1993","article-title":"EWS\/FLI1 oncogene activates caspase 3 transcription and triggers apoptosis in vivo","volume":"70","author":"Sohn","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0240","doi-asserted-by":"crossref","first-page":"5040","DOI":"10.1158\/0008-5472.CAN-15-3422","article-title":"Activation of Wnt\/\u03b2-catenin in Ewing sarcoma cells antagonizes EWS\/ETS function and promotes phenotypic transition to more metastatic cell states","volume":"76","author":"Pedersen","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0245","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/1947601912457024","article-title":"The EWS\/FLI oncogene drives changes in cellular morphology, adhesion, and migration in Ewing sarcoma","volume":"3","author":"Chaturvedi","year":"2012","journal-title":"Genes Cancer"},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0250","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1091\/mbc.e14-01-0007","article-title":"Molecular dissection of the mechanism by which EWS\/FLI expression compromises actin cytoskeletal integrity and cell adhesion in Ewing sarcoma","volume":"25","author":"Chaturvedi","year":"2014","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0255","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41389-020-00294-8","article-title":"YAP\/TAZ inhibition reduces metastatic potential of Ewing sarcoma cells","volume":"10","author":"Bierbaumer","year":"2021","journal-title":"Oncogenesis"},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0260","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.ccell.2021.05.007","article-title":"STAG2 loss rewires oncogenic and developmental programs to promote metastasis in Ewing sarcoma","volume":"39","author":"Adane","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0265","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.18632\/oncotarget.27737","article-title":"KDM5A and PHF2 positively control expression of pro-metastatic genes repressed by EWS\/Fli1, and promote growth and metastatic properties in Ewing sarcoma","volume":"11","author":"McCann","year":"2020","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0270","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.3390\/cancers14071762","article-title":"miR-214-3p is commonly downregulated by EWS-FLI1 and by CD99 and its restoration limits Ewing sarcoma aggressiveness","volume":"14","author":"De Feo","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0275","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.celrep.2020.01.049","article-title":"Transcriptional programs define intratumoral heterogeneity of Ewing sarcoma at single-cell resolution","volume":"30","author":"Aynaud","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0280","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s13402-021-00640-x","article-title":"Single-cell RNA profiling identifies diverse cellular responses to EWSR1\/FLI1 downregulation in Ewing sarcoma cells","volume":"45","author":"Khoogar","year":"2022","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0285","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nature11005","article-title":"Systematic identification of genomic markers of drug sensitivity in cancer cells","volume":"483","author":"Garnett","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0290","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aam8429","article-title":"Inhibition of the oncogenic fusion protein EWS-FLI1 causes G 2-M cell cycle arrest and enhanced vincristine sensitivity in Ewing\u2019s sarcoma","volume":"10","author":"Z\u00f6llner","year":"2017","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0295","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1158\/1078-0432.CCR-14-2112","article-title":"SLFN11 is a transcriptional target of EWS-FLI1 and a determinant of drug response in Ewing sarcoma","volume":"21","author":"Tang","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0300","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1158\/1541-7786.MCR-23-0323","article-title":"USP1 expression driven by EWS::FLI1 transcription factor stabilizes Survivin and mitigates replication stress in Ewing sarcoma","volume":"21","author":"Mallard","year":"2023","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0305","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1002\/cam4.1589","article-title":"Friend leukemia virus integration 1 is a predictor of poor prognosis of breast cancer and promotes metastasis and cancer stem cell properties of breast cancer cells","volume":"7","author":"Yan","year":"2018","journal-title":"Cancer Med."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0310","doi-asserted-by":"crossref","first-page":"23764","DOI":"10.18632\/oncotarget.4350","article-title":"Friend leukemia virus integration 1 activates the Rho GTPase pathway and is associated with metastasis in breast cancer","volume":"6","author":"Song","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0315","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/cdd.2015.78","article-title":"Stromal miR-200s contribute to breast cancer cell invasion through CAF activation and ECM remodeling","volume":"23","author":"Tang","year":"2016","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0320","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1111\/jcmm.15205","article-title":"Characterization of the relationship between FLI1 and immune infiltrate level in tumour immune microenvironment for breast cancer","volume":"24","author":"Wang","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0325","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s12864-024-10174-9","article-title":"Integrated analysis reveals FLI1 regulates the tumor immune microenvironment via its cell-type-specific expression and transcriptional regulation of distinct target genes of immune cells in breast cancer","volume":"25","author":"Pei","year":"2024","journal-title":"BMC Genomics"},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0330","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1002\/ptr.6426","article-title":"Prospect of natural products in glioma: a novel avenue in glioma management","volume":"33","author":"Kundu","year":"2019","journal-title":"Phyther. Res."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0335","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.canlet.2019.10.034","article-title":"Imatinib revives the therapeutic potential of metformin on Ewing sarcoma by attenuating tumor hypoxic response and inhibiting convergent signaling pathways","volume":"469","author":"Nan","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0340","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/jcmm.14735","article-title":"Circular RNA USP1 regulates the permeability of blood-tumour barrier via miR-194-5p\/FLI1 axis","volume":"24","author":"Gao","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0345","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1248\/bpb.b13-00920","article-title":"The GANT61, a GLI inhibitor, induces caspase-independent apoptosis of SK-N-LO cells","volume":"37","author":"Matsumoto","year":"2014","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0350","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s13277-010-0046-4","article-title":"CD133+ cells from medulloblastoma and PNET cell lines are more resistant to cyclopamine inhibition of the sonic hedgehog signaling pathway than CD133\u2212 cells","volume":"31","author":"Enguita-Germ\u00e1n","year":"2010","journal-title":"Tumour Biol."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0355","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.pharmthera.2012.08.004","article-title":"Prevailing importance of the hedgehog signaling pathway and the potential for treatment advancement in sarcoma","volume":"136","author":"Kelleher","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0360","first-page":"2079","article-title":"Gliosarcoma with primitive neuroectodermal, osseous, cartilage and adipocyte differentiation: a case report","volume":"8","author":"Yao","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0365","doi-asserted-by":"crossref","DOI":"10.3892\/ijo_00000161","article-title":"Dominant-negative inhibition of Ets 1 suppresses tumor growth, invasion and migration in rat C6 glioma cells and reveals differentially expressed Ets 1 target genes","author":"Wernert","year":"1992","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0370","first-page":"1196","article-title":"Delineation of crosstalk between HSP27 and MMP-2\/MMP-9: a synergistic therapeutic avenue for glioblastoma management","volume":"2019","author":"Rajesh","year":"1863","journal-title":"Biochim. Biophys. Acta-Gen. Subj."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0375","doi-asserted-by":"crossref","first-page":"12324","DOI":"10.1073\/pnas.1921531117","article-title":"Lumefantrine, an antimalarial drug, reverses radiation and temozolomide resistance in glioblastoma","volume":"117","author":"Rajesh","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0380","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/gcc.20948","article-title":"FLI1 is a novel ETS transcription factor involved in gene fusions in prostate cancer","volume":"51","author":"Paulo","year":"2012","journal-title":"Genes, Chromosom. Cancer."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0385","doi-asserted-by":"crossref","DOI":"10.1200\/PO.22.00048","article-title":"Prospective clinical genomic profiling of Ewing sarcoma: ERF and FGFR1 mutations as recurrent secondary alterations of potential biologic and therapeutic relevance","author":"Ogura","year":"2022","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0390","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1101\/gr.151340.112","article-title":"Oncogenic ETS fusions deregulate E2F3 target genes in Ewing sarcoma and prostate cancer","volume":"23","author":"Bilke","year":"2013","journal-title":"Genome Res."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0395","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1093\/nar\/gkv123","article-title":"EWS-FLI1 employs an E2F switch to drive target gene expression","volume":"43","author":"Schwentner","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0400","doi-asserted-by":"crossref","DOI":"10.1172\/JCI169470","article-title":"Oncogenic ETS fusions promote DNA damage and proinflammatory responses via pericentromeric RNAs in extracellular vesicles","volume":"134","author":"Ruzanov","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0405","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24460","article-title":"Super enhancer-LncRNA SENCR promoted cisplatin resistance and growth of NSCLC through upregulating FLI1","volume":"36","author":"Shen","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0410","article-title":"Blocking ACSL6 compromises autophagy via FLI1-mediated downregulation of COLs to radiosensitize lung cancer","volume":"11","author":"Ding","year":"2024","journal-title":"Adv. Sci. (Weinheim, Baden-Wurttemberg, Ger.)"},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0415","doi-asserted-by":"crossref","first-page":"41975","DOI":"10.18632\/oncotarget.16715","article-title":"Friend leukemia virus integration 1 promotes tumorigenesis of small cell lung cancer cells by activating the miR-17-92 pathway","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0420","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1158\/1078-0432.CCR-18-1447","article-title":"FLI1 Exonic circular RNAs as a novel oncogenic driver to promote tumor metastasis in small cell lung cancer","volume":"25","author":"Li","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0425","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s42003-023-04561-3","article-title":"FLI1 and FRA1 transcription factors drive the transcriptional regulatory networks characterizing muscle invasive bladder cancer","volume":"6","author":"Guneri-Sozeri","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0430","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.pan.2020.10.033","article-title":"Expression of the EWSR1-FLI1 fusion oncogene in pancreas cells drives pancreatic atrophy and lipomatosis","volume":"20","author":"Fahr","year":"2020","journal-title":"Pancreatology"},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0435","article-title":"Hsa_circ_0007401 regulates gemcitabine resistance of pancreatic cancer through the hsa-miR-6509-3p\/fli1 axis","volume":"102","author":"Han","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0440","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.omtn.2020.12.013","article-title":"circCAMSAP1 promotes osteosarcoma progression and metastasis by sponging miR-145-5p and regulating FLI1 expression","volume":"23","author":"Chen","year":"2021","journal-title":"Mol. Ther. - Nucleic Acids."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0445","doi-asserted-by":"crossref","first-page":"6032","DOI":"10.3390\/ijms24076032","article-title":"Identification of Mir-182-3p\/FLI-1 Axis as a key signaling in immune response in cervical cancer: a comprehensive bioinformatic analysis","volume":"24","author":"Salmer\u00f3n-B\u00e1rcenas","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0450","first-page":"364","article-title":"<scp>DNMT3b<\/scp> affects colorectal cancer development by regulating <scp>FLI1<\/scp> through <scp>DNA<\/scp> hypermethylation, Kaohsiung","volume":"39","author":"Zhou","year":"2023","journal-title":"J. Med. Sci."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0455","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1158\/1078-0432.CCR-18-3511","article-title":"Trabectedin inhibits EWS-FLI1 and evicts SWI\/SNF from chromatin in a schedule-dependent manner","volume":"25","author":"Harlow","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0460","doi-asserted-by":"crossref","first-page":"6657","DOI":"10.1158\/0008-5472.CAN-16-0568","article-title":"Lurbinectedin inactivates the Ewing sarcoma oncoprotein EWS-FLI1 by redistributing it within the nucleus","volume":"76","author":"Harlow","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0465","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.chembiol.2022.06.002","article-title":"TK216 targets microtubules in Ewing sarcoma cells","volume":"29","author":"Povedano","year":"2022","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0470","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040122","article-title":"Signature-based small molecule screening identifies cytosine arabinoside as an EWS\/FLI modulator in Ewing sarcoma","volume":"4","author":"Stegmaier","year":"2007","journal-title":"PLoS Med."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0475","doi-asserted-by":"crossref","first-page":"37678","DOI":"10.18632\/oncotarget.5520","article-title":"YK-4-279 effectively antagonizes EWS-FLI1 induced leukemia in a transgenic mouse model","volume":"6","author":"Minas","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0480","doi-asserted-by":"crossref","first-page":"94780","DOI":"10.18632\/oncotarget.21933","article-title":"EWS-FLI1 and RNA helicase A interaction inhibitor YK-4-279 inhibits growth of neuroblastoma","volume":"8","author":"Sun","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0485","doi-asserted-by":"crossref","first-page":"10290","DOI":"10.1021\/jm501372p","article-title":"Synthesis and structure\u2013activity relationship studies of small molecule disruptors of EWS-FLI1 interactions in Ewing's sarcoma","volume":"57","author":"Tosso","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0490","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41388-022-02533-1","article-title":"Therapeutic targeting the oncogenic driver EWSR1::FLI1 in Ewing sarcoma through inhibition of the FACT complex","volume":"42","author":"Mo","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0495","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.406","article-title":"Silencing FLI or targeting CD13\/ANPEP lead to dephosphorylation of EPHA2, a mediator of BRAF inhibitor resistance, and induce growth arrest or apoptosis in melanoma cells","volume":"8","author":"Azimi","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0500","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202004846","article-title":"SPOP and OTUD7A control EWS\u2013FLI1 protein stability to govern Ewing sarcoma growth","volume":"8","author":"Su","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215984","article-title":"Ablation of EWS-FLI1 by USP9X inhibition suppresses cancer cell growth in Ewing sarcoma","volume":"552","author":"Wang","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0510","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/jnci\/djr156","article-title":"Identification of an inhibitor of the EWS-FLI1 oncogenic transcription factor by high-throughput screening","volume":"103","author":"Grohar","year":"2011","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0515","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1158\/1538-7445.AM2019-2882","article-title":"Abstract 2882: mithramycin impedes EWS-FLI1 driven transcription by preventing target promoter clearance","volume":"79","author":"Flores","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0520","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.ijrobp.2020.12.010","article-title":"Mithramycin a radiosensitizes EWS:Fli1+ Ewing sarcoma cells by inhibiting double strand break repair","volume":"109","author":"Lin","year":"2021","journal-title":"Int. J. Radiat. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0525","doi-asserted-by":"crossref","first-page":"10058","DOI":"10.1074\/jbc.M115.701375","article-title":"Englerin a inhibits EWS-FLI1 DNA binding in Ewing sarcoma cells","volume":"291","author":"Caropreso","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0530","doi-asserted-by":"crossref","first-page":"9802","DOI":"10.1002\/cam4.5741","article-title":"Screening for <scp>DAX1<\/scp>\/<scp>EWS-FLI1<\/scp> functional inhibitors identified dihydroorotate dehydrogenase as a therapeutic target for Ewing's sarcoma","volume":"12","author":"Watanabe","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0535","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3892\/ijo.2013.2016","article-title":"The dual inhibitory effect of thiostrepton on FoxM1 and EWS\/FLI1 provides a novel therapeutic option for Ewing's sarcoma","volume":"43","author":"Sengupta","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0540","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s00109-019-01782-0","article-title":"Targeted inhibition of histone deacetylase leads to suppression of Ewing sarcoma tumor growth through an unappreciated EWS-FLI1\/HDAC3\/HSP90 signaling axis","volume":"97","author":"Ma","year":"2019","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0545","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1002\/ijc.27472","article-title":"Small-molecule screen identifies modulators of EWS\/FLI1 target gene expression and cell survival in Ewing\u2019s sarcoma","volume":"131","author":"Boro","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0550","doi-asserted-by":"crossref","first-page":"28895","DOI":"10.18632\/oncotarget.5000","article-title":"PI3K\/AKT signaling modulates transcriptional expression of EWS\/FLI1 through specificity protein 1","volume":"6","author":"Giorgi","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0555","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/s41467-025-56632-0","article-title":"The O-glycosyltransferase C1GALT1 promotes EWSR1::FLI1 expression and is a therapeutic target for Ewing sarcoma","volume":"16","author":"Banday","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0560","doi-asserted-by":"crossref","first-page":"43504","DOI":"10.18632\/oncotarget.9762","article-title":"BET bromodomain inhibitors suppress EWS-FLI1-dependent transcription and the IGF1 autocrine mechanism in Ewing sarcoma","volume":"7","author":"Loganathan","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0565","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s13046-021-02125-z","article-title":"Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis","volume":"40","author":"Schmidt","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0570","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1158\/1535-7163.MCT-20-0489","article-title":"Pharmaceutical interference of the EWS-FLI1\u2013driven transcriptome by cotargeting H3K27ac and RNA polymerase activity in Ewing sarcoma","volume":"20","author":"Heisey","year":"2021","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0575","doi-asserted-by":"crossref","first-page":"31397","DOI":"10.18632\/oncotarget.25829","article-title":"The combination of epigenetic drugs SAHA and HCI-2509 synergistically inhibits EWS-FLI1 and tumor growth in Ewing sarcoma","volume":"9","author":"Garc\u00eda-Dom\u00ednguez","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0580","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.3390\/ijms21062216","article-title":"Fli-1 activation through targeted promoter activity regulation using a novel 3\u2032, 5\u2032-diprenylated chalcone inhibits growth and metastasis of prostate cancer cells","volume":"21","author":"Ma","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0585","doi-asserted-by":"crossref","first-page":"16728","DOI":"10.18632\/oncotarget.14377","article-title":"A screen for Fli-1 transcriptional modulators identifies PKC agonists that induce erythroid to megakaryocytic differentiation and suppress leukemogenesis","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0590","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00280-017-3382-x","article-title":"A phase I\/II trial and pharmacokinetic study of mithramycin in children and adults with refractory Ewing sarcoma and EWS\u2013FLI1 fusion transcript","volume":"80","author":"Grohar","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0595","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1200\/JCO.24.00020","article-title":"Open-label, multicenter, phase I\/II, first-in-human trial of TK216: a first-generation EWS::FLI1 fusion protein antagonist in Ewing sarcoma","volume":"42","author":"Meyers","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0600","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/pbc.21822","article-title":"Phase II study of intermediate-dose cytarabine in patients with relapsed or refractory Ewing sarcoma: a report from the Children\u2019s Oncology Group","volume":"52","author":"DuBois","year":"2009","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0605","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1158\/1078-0432.CCR-22-0696","article-title":"Antitumor activity of Lurbinectedin, a selective inhibitor of oncogene transcription, in patients with relapsed Ewing sarcoma: results of a basket phase II study","volume":"28","author":"Subbiah","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0610","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1158\/1535-7163.MCT-14-0334","article-title":"An oral formulation of YK-4-279: preclinical efficacy and acquired resistance patterns in Ewing sarcoma","volume":"14","author":"Lamhamedi-Cherradi","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0615","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1158\/1078-0432.CCR-15-2624","article-title":"Identification of mithramycin analogues with improved targeting of the EWS-FLI1 transcription factor","volume":"22","author":"Osgood","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.143080_bb0620","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1158\/1535-7163.MCT-19-0775","article-title":"CDK9 blockade exploits context-dependent transcriptional changes to improve activity and limit toxicity of mithramycin for Ewing sarcoma","volume":"19","author":"Flores","year":"2020","journal-title":"Mol. Cancer Ther."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025036323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025036323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:42:35Z","timestamp":1782927755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025036323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":124,"alternative-id":["S0141813025036323"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.143080","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting friend leukemia integration 1: A promising approach for prevention and treatment of solid tumors","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.143080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"143080"}}